245 related articles for article (PubMed ID: 18925455)
1. Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs.
Maas C; Schiks B; Strangi RD; Hackeng TM; Bouma BN; Gebbink MF; Bouma B
Amyloid; 2008 Sep; 15(3):166-80. PubMed ID: 18925455
[TBL] [Abstract][Full Text] [Related]
2. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface.
Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A
Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318
[TBL] [Abstract][Full Text] [Related]
3. Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity.
Van Nostrand WE; Porter M
Biochemistry; 1999 Aug; 38(35):11570-6. PubMed ID: 10471309
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator binds to Aβ and AIAPP amyloid fibrils with multiple domains.
Beringer DX; Fischer MJ; Meeldijk JD; van Donselaar EG; de Mol NJ; Kroon-Batenburg LM
Amyloid; 2013 Jun; 20(2):113-21. PubMed ID: 23697555
[TBL] [Abstract][Full Text] [Related]
5. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms.
Cacquevel M; Launay S; Castel H; Benchenane K; Chéenne S; Buée L; Moons L; Delacourte A; Carmeliet P; Vivien D
Neurobiol Dis; 2007 Aug; 27(2):164-73. PubMed ID: 17566751
[TBL] [Abstract][Full Text] [Related]
6. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
Rydzewski A; Castellino FJ
Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
[TBL] [Abstract][Full Text] [Related]
7. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-beta-stimulated plasminogen activation by tissue-type plasminogen activator results in processing of neuroendocrine factors.
Kranenburg O; Gent YY; Romijn EP; Voest EE; Heck AJ; Gebbink MF
Neuroscience; 2005; 131(4):877-86. PubMed ID: 15749342
[TBL] [Abstract][Full Text] [Related]
9. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
10. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
[TBL] [Abstract][Full Text] [Related]
11. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.
Renatus M; Engh RA; Stubbs MT; Huber R; Fischer S; Kohnert U; Bode W
EMBO J; 1997 Aug; 16(16):4797-805. PubMed ID: 9305622
[TBL] [Abstract][Full Text] [Related]
12. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
Schousboe I; Nystrøm BT; Hansen GH
FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
[TBL] [Abstract][Full Text] [Related]
13. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator.
Moser TL; Enghild JJ; Pizzo SV; Stack MS
J Biol Chem; 1993 Sep; 268(25):18917-23. PubMed ID: 8360181
[TBL] [Abstract][Full Text] [Related]
14. Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors).
Gebbink MF; Bouma B; Maas C; Bouma BN
FEBS Lett; 2009 Aug; 583(16):2691-9. PubMed ID: 19527723
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
Lobov S; Croucher DR; Saunders DN; Ranson M
Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of human polyserase-3, a novel protein with tandem serine-protease domains in the same polypeptide chain.
Cal S; Peinado JR; Llamazares M; Quesada V; Moncada-Pazos A; Garabaya C; López-Otín C
BMC Biochem; 2006 Mar; 7():9. PubMed ID: 16566820
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the glycosylated second type 2 module of fibronectin.
Sticht H; Pickford AR; Potts JR; Campbell ID
J Mol Biol; 1998 Feb; 276(1):177-87. PubMed ID: 9514732
[TBL] [Abstract][Full Text] [Related]
18. Extended and flexible domain solution structure of the extracellular matrix protein anosmin-1 by X-ray scattering, analytical ultracentrifugation and constrained modelling.
Hu Y; Sun Z; Eaton JT; Bouloux PM; Perkins SJ
J Mol Biol; 2005 Jul; 350(3):553-70. PubMed ID: 15949815
[TBL] [Abstract][Full Text] [Related]
19. Activation of human platelets by misfolded proteins.
Herczenik E; Bouma B; Korporaal SJ; Strangi R; Zeng Q; Gros P; Van Eck M; Van Berkel TJ; Gebbink MF; Akkerman JW
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1657-65. PubMed ID: 17510465
[TBL] [Abstract][Full Text] [Related]
20. The ShdA adhesin binds to the cationic cradle of the fibronectin 13FnIII repeat module: evidence for molecular mimicry of heparin binding.
Kingsley RA; Keestra AM; de Zoete MR; Bäumler AJ
Mol Microbiol; 2004 Apr; 52(2):345-55. PubMed ID: 15066025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
